International Conference on Herbal Medicine

The National Herbalists Association of Australia recently hosted the 8th International Conference on Herbal Medicine, in Melbourne. It was a great event, running over three days and attended by over 400 delegates; a combination of herbalists, naturopaths, pharmacists, doctors and students.

Sinusitis: not just a seasonal complaint

Now that we’re well into Autumn, and the temperature is beginning to drop, many people have been experiencing seasonal coughs, colds and infections. And for some, this will also mean one or more bouts of sinusitis. Any condition that impairs the normal drainage of the sinuses – including a respiratory infection or allergy – can lead to sinusitis.

Expert speakers at Flordis Midlife Women seminar

In April, Flordis will be running two specialist seminars for healthcare professionals, looking at the latest research and best evidence for the treatment of health issues facing midlife women. We are excited to have some very prestigious speakers presenting research at these collaborative events, including Ruth Trickey and Dr Elizabeth Farrell.

Flordis out and about

Over the past few weeks, you may have noticed some interesting installations in your local pharmacy or health food store. Our wonderful sales representatives have been working hard to create eye-catching Flordis displays for everyone to enjoy.

Flordis products feature in medical text books

Two new medical text books have been published in recent months that both discuss the research and evidence behind some of Flordis’ clinically proven products.

Give yourself a fresh start for the New Year

After celebrating the festive season - and most likely over indulging! - many people will consider doing a detox so that they can begin the new year feeling good. Detoxification is the body’s natural process of eliminating unwanted waste products and toxins that accumulate over time.

Office hours over the Festive Season

All of us here at Flordis would like to wish you a happy and healthy festive season. We’d also like to thank you for your support during 2012 and look forward to an exciting year ahead!

The Flordis mobile site goes live!

We are proud to announce that following on from the website update in August, our new mobile-friendly site is live this week!

International Symposium on Diet and Health

In October, one of Flordis’ regulatory and project coordinators, Dr Dilip Ghosh, presented at an international health symposium in Niigata, Japan. The aim of the symposium was to address the scientific basis for the role of food in disease prevention and health promotion.

Dr Ghosh discussed the standardisation of natural medicine products and importance of “seed to patient” specificity for the best results in clinic.

First-of-a-kind joint ventures tap into global demand for natural medicines

Soho Flordis International and China Shineway Pharmaceutical forge Australia/Asia link to boost share of growing AUD$80B global market

Sydney, Australia, 22 November 2012 -- Evidence-based natural medicines from Soho Flordis International (SFI) and China Shineway Pharmaceutical Group will be developed and promoted in China and globally thanks to the establishment of two joint ventures, it was announced today.
Read more...

On a Roll with AgioFibe and Agiolax

You may have noticed some interesting additions in your local pharmacy recently! Our new ‘On a Roll’ campaign takes a tongue-in-cheek look at dietary fibre and laxative fibre supplements - a traditionally conservative and ‘uncomfortable’ category.

New research confirms a simple solution for women seeking a natural way to go with the flow – period!

International study is first to confirm most effective dose of Premular® (herbal extract Vitex agnus castus Ze 440) to treat premenstrual syndrome (PMS)

Sydney, Australia – 29 October 2012 – A new international study has confirmed for the first time that the standard once-daily dose of Premular® gives the most effective relief from the debilitating symptoms of PMS.1

Flordis speaker at National CHC Conference

One of our regulatory and project coordinators, Dr Dilip Ghosh, spoke at the recent Complementary Healthcare Council (CHC) conference in Sydney. He talked about the “long and winding road” from AUST L to AUST R registration. The registration of natural medicines through the Therapeutic Goods Administration (TGA) requires extensive data that demonstrates quality, safety and efficacy; not unlike the requirements for a prescription product.

Flordis Receives Best Complementary Medicine Award for Iberogast

Recognition from Australian pharmacists confirms top spot for clinically proven natural medicines

Flordis, one of Australia’s leading providers of evidence based natural medicines, has been awarded one of the industry’s most sought after awards at the annual Australian Journal of Pharmacy (AJP) Awards, winning Best Complementary Medicine Product of the Year for its flagship product Iberogast.

Flordis Sponsors Mechanism-based Natural Product Development Conference

Providing a unique opportunity for scientists and business leaders from around the world to discuss the latest discoveries and developments in natural medicines, the Mechanism-based Natural Product Development Conference during September 2012 in Whistler, Canada, is sponsored by Flordis.

The conference will dedicate two days to in-depth and thought-provoking discussion on the discovery and development of therapeutic natural medicines and the integration of complementary and orthodox medicines for better health outcomes.

Flordis joins new group to raise the evidence base of complementary medicines

Flordis natural medicines is proud to be a partner in a new collaboration of industry, academia, and consumers, which will press for a stronger evidence base to support complementary medicines (CM) in Australia, Managing Director, Craig Weller said today.

The initiative was launched by Dr Ken Harvey, Adjunct Senior Lecturer in the School of Public Health, La Trobe University, at the Gold Coast today.

Survey shows that GPs seek natural medicine brands with clinical evidence

A new study has found that three-quarters of GPs are reluctant to recommend natural medicines because of a lack of clinical evidence.

The research found that natural medicines are discussed in approximately 20% of GP consultations, and are recommended by GPs in 13% of consultations.

The study was commissioned by leading Australian clinically proven natural medicines company, Flordis, and undertaken by global health and medical research firm, IMS. It gathered information about the views of GPs towards the use and awareness of natural medicine products and brands.

Flordis proud to support national complementary medicines agency funding

Leading Australian natural medicines company, Flordis, is pleased to support the National Institute of Complementary Medicine (NICM), as part of the Institute’s funding announcement made in Sydney today.

NICM has received $2.9 million in funding from philanthropic and industry donors, with the largest element being a $2 million bequest from the privately owned Jacka Foundation of Natural Therapies. Read more...

Flordis proudly sponsors the Swinburne University brain health and natural medicine conference

We are reminded about the importance of brain health every day in practice as our patients present with mental conditions such as depression, anxiety, stress related illness, insomnia, decline in memory and Attention Deficit Hyperactivity Disorder. As natural medicine practitioners we have many wonderful brain health herbal allies, many of which will be the subject of an upcoming event entitled 'Brain health and natural medicine’. Read more...

Evidence–based natural medicines company signs up GP detailing team

Flordis will be expanding the reach of its range of specifically clinically proven natural medicines, through a new initiative that will bring the products to the attention of general practitioners (GPs). Flordis’ Managing Director, Craig Weller says that since the company’s products meet the same high clinical standards as pharmaceutical products, it makes sense to enable GPs to learn more about how they can benefit patients.

Flordis natural medicines to go national under new agreement with wholesalers

Flordis specifically clinically proven natural medicines will be available through pharmacies across Australia under a national distribution agreement with Sigma, Symbion and Australian Pharmaceutical Industries (API), announced today.

Flordis has also engaged PharmaBrokers to provide a contract sales team.

Media Release: Clinically proven natural medicine wins the support of top medicos as new clinical trial progresses

One of Australia’s leading gastroenterologists says he believes that a clinically proven herbal product has its place among, and is probably at least as effective as, more expensive mainstream treatments for common gastrointestinal disorders that impact thousands of Australians.

Functional GI Disease: Solving the Therapeutic Dilemma

Iberogast® (STW 5) was the subject of a symposium on “Functional GI Disease: Solving the Therapeutic Dilemma” held as part of the European Bridging Meeting in Gastroenterology in Berlin, Germany. Here Iberogast was recognised as the only phytotherapeutical remedy which fulfills the description of a multi-target product.

Flordis/SFI commits to sharpen minds with ABC's Adopt-An-Herb for Bacopa

The adoption of Bacopa monnieri (brahmi) by Flordis/SFI with the American Botanical Council’s Adopt-An-Herb program will ensure up-to-date clinical information on Bacopa monnieri, which will be easily available via HerbMedPro. HerbMedPro is an electronic herbal database that provides hyperlinked access to the scientific data underlying the use of herbs for health. It is an evidence-based information resource for healthcare professionals, researchers and the general public.

EMEA singles out Premular as the only evidence-based Vitex

The European Medicines Agency (EMEA) has granted Premular, specific extract of Vitex agnus-castus (Ze 440) a “well-established use” classification “for the treatment of premenstrual syndrome” based on proof of efficacy and safety.1,2

Premular is the only Vitex product to be assigned this status by the EMEA with all other Vitex products assigned to “traditional use” status because of insufficient evidence.1,2

BMJ makes U-turn statement on glucosamine study

BMJ makes U-turn statement on glucosamine study January 2011: the British Medical Journal has released a statement following a Post Publication Review Meeting on the recently published meta-analysis of Wandel et al, which questioned the clinical relevance of the effects of glucosamine (and chondroitin, and their combination) in osteoarthritis.

At this review meeting, the BMJ editors were obliged to state that the authors’ conclusions

The Brahmi Army-KeenMind CDRI 08 delegation sent to India

Banaras Hindu University, Varanasi, India: A Satellite Symposium on ‘Brain Ageing and Dementia: Basic and Translational Aspects’ acted as the platform for the international neuroscience research community to discuss age related dementia and neurodegenerative disorders. The symposium was organised by the Federation of Asian-Oceanian Neuroscience Societies (FAONS) and the Indian Academy of Neurosciences (IAN).

Flordis Research Update

Flordis Research Update

The end of the year seems a fitting time to review the ongoing research on 4 of the Flordis specifically clinically proven products. At Flordis, we are committed to bringing you the best evidenced natural products from around the world, which is why to be part of the range, each product has to have an established body of published data. We are also dedicated to encouraging ongoing research for our products and as such, work closely with Australian researchers.

Current Perspective on glucosamine sulphate as a disease modifying agent in osteoarthritis

On September 23-26, the annual OARSI World Congress on Osteoarthritis was held in Brussels for those involved in osteoarthritis (OA) research and treatment. The congress featured speakers from around the world, presenting wide spectrum of topics related to cartilage and OA.

A satellite symposium was organised by Rottapharm/Madaus (the European manufacturer of DONA® Glucosamine), with the purpose of addressing Current perspectives on the clinical use of glucosamine sulphate (GS) as a disease modifying agent in osteoarthritis.

The symposiums key points included:

Complementary therapy is a blend of gobbledygook, treatments of dubious value and genuinely useful medicines

Peddlers of "natural" potions and pills will be delighted with the finding that complementary medicines ease the pressure on the strained health budget.

The Advertiser, 14th September 2010

Read More

First herbal medicine to have its effectiveness acknowleged by the TGA

For the first time, the Therapeutic Goods Administration (TGA) has evaluated and subsequently registered a herbal medicine product based on its efficacy via the registration pathway for complementary medicines.

This product is Iberogast^® (STW 5) from Flordis which the TGA has registered (AUST R) for the treatment of functional dyspepsia and Irritable Bowel Syndrome (IBS).
Read more...

Flordis launches Sinupret Forte!

Just in time for this winter’s cold and flu season, Flordis is launching Sinupret Forte® which is clinically proven to relieve symptoms of sinusitis, sinus pain and mild upper respiratory tract infections.

Sinupret was developed by herbalists early in the last century and has been used extensively by naturopaths and doctors worldwide for 77 years. Originally, it was a liquid formulation; however, over the years, this galenical preparation has been developed into Sinupret tablets and Sinupret Forte tablets joining the original in 1968 and 1997.

Iberogast celebrates its 50th Birthday

Iberogast (STW 5) has celebrated its golden anniversary with a conference in Germany entitled, “50 Years of Iberogast”.

During its 50 years of development and use, Iberogast has become one of the most extensively investigated herbal medicinal products and is verified by the highest levels of scientific evidence for the treatment of functional gastrointestinal disease e.g. IBS and dyspepsia.
Read more...

Introducing Flordis Nutritionals

Today, Flordis has launched a new range called Flordis Nutritionals, which has been formulated by a team of with over 150 years of combined clinical experience.

The Nutritionals Range consists of three new products: Multivitamins and Minerals, Enteric Coated Omega 3 Fish Oil and Muscle & Cell Replenishment, which join our existing Nutritionals product, D3-1000™ Vitamin D3. These Australian manufactured products contain therapeutic doses of the highest quality ingredients, formulated specifically to meet the clinical needs of Australian health care practitioners.
Read more...

The Australian launch of the ‘Gold Standard’ in Panax Ginseng – Ginsana® (G115)

A recent survey (IMS 2008) established that malaise and fatigue are the most medically untreated complaints reported by 95.4% of patients.

In answer to the ‘chronically tired’ patient, Flordis has today launched Ginsana (G115), the ‘gold standard’ and most scientifically researched ginseng product in the world.

Panax ginseng (named ‘Panax ginseng’ by the Russian botanist Carl Anton Meyer in 1843) is one of the most renowned tonics especially in the Chinese Materia Medica. Its usage was first documented over 2000 years ago.

KeenMind wins ARC Discovery Grant

The Australian Research Council (ARC) has awarded a highly prestigious ARC Discovery Grant to Swinburne University of Technology for research into healthy ageing with the special extract of Bacopa monnieri, KeenMind® (CDRI 08).

Leading the research will be Professor Con Stough who is the principle investigator of KeenMind studies at Swinburne’s Brain Sciences Institute. The large scale study will use KeenMind in 310 healthy elderly participants for a period of 12 months to determine KeenMind’s role in reducing the cognitive effects of ageing.
Read more...

Flordis gives support to the establishment of an Australian register of naturopaths and herbalists

Today, Flordis gives its full support to the establishment of an independent steering committee dedicated to forming The Australian Register of Naturopaths and Herbalists (ARONAH).

Flordis is an Australian company dedicated to meeting the public and health care system’s demand for natural but specifically clinically proven medicine.

Flordis adds its name to the independent register, expected to be fully operational by mid-2010. This will provide minimum standards of education and practice for naturopaths and herbalists.
Read more...

World experts on neurocognition unveil the latest evidence-based research at Fapronatura 2009

This week, the enhancement of cognitive abilities through the use of evidence-based herbal medicines will be in the spotlight at the Second International Symposium about Pharmacology of Natural Products (FAPRONATURA 2009).

The conference will take place in Varadero, Cuba on the 3rd – 7th of June. It is organised by the Cuban Society of Pharmacology and will bring together international researchers and opinion leaders in the field of pharmacology of natural medicines.

Natural alternative targets nicotine addiction in a unique way

On the eve of World No Tobacco Day, leading Australian researcher, Professor Con Stough, calls for natural smoking cessation alternatives to be taken seriously.
 
Professor Stough, Brain Sciences Institute, Swinburne University of Technology, Melbourne has been involved in the world’s first studies of a Hypericum perforatum (Ze 117) product compared to transdermal Nicotine Replacement Therapy, and the combination of both, in the management of smoking cessation.
Read more...

Vitamin D3 joins Flordis Nutritionals

Flordis D3 – 1000 is the latest addition to Flordis Nutritionals. Vitamin D3 (cholecalciferol) is the natural, active form of vitamin D. Vitamin D3 plays an integral role in calcium and bone metabolism and supports healthy living

For improved compliance and practicality, Flordis D3 – 1000 is packaged as easy to take tablets providing 3 months supply. It is derived naturally from lanolin gathered from healthy Australian and New Zealand sheep. It contains no added sugar gluten, lactose, dairy products, artificial colours, flavours or preservatives

KeenMind is here!

Flordis are excited to announce the launch of KeenMind® – this meticulously researched and clinically proven Bacopa monnieri extract is arguably the most exciting addition to the Flordis range of practitioner prescribed natural medicines.
Read more...

Flordis receives herbal medicine award

Yesterday Flordis received the Inaugural Innovative Herbal Medicine Award from the National Herbalists Association of Australia (NHAA) at their 6th International Conference on Phytotherapeutics. Read more...

Australian Iberogast study published - May 2007

An Australian study on how Iberogast works

A study conducted at the Royal Adelaide hospital was recently published in the American Journal of Gastroenterology. The study looked at the effect Iberogast had on the functioning of the human gastrointestinal tract in order to determine how Iberogast worked.
Read more...

PHH Seminars 2007

Much more than hormones: Assessment and treatment of women at mid-life. Naturopath and womens health expert Sandra Villella examines the often overlooked health factors associated with female patients at the various stages of mid-life. Read more...

Tis the season of stomach ache!

Leading gut researcher Professor Gerald Holtmann from the Royal Adelaide Hospital is working on helping the 4 million Australians who will suffer pain and nausea after Christmas dinner. This is not those of us who over indulge, but 20% of Australians have "sensitive guts" which make it hard to enjoy a good meal.
Read more...

Legalon is here!

Flordis are excited to announce the launch of Legalon® – the extensively researched, clinically proven silymarin extract manufactured by Madaus in Germany. Over 200 published studies have demonstrated Legalon’s positive effect on liver health, also supported by more than 40 years of clinical use.

Extensive research over many decades supports the use of Legalon – yet again, Flordis provides healthcare practitioners with the same silymarin extract used in clinical studies.
Read more...

Prescribing Holistic Health Conference

"Prescribing Holistic Health was conceived from a common goal to support professional, evidence-based holistic health care in the Australian community. To keep up to date with this ever changing field is an enormous task, particularly as many holistic approaches are not promoted. It is to help Australian practitioners that this conference has been organised. Read more...

Ground-breaking local research on Iberogast

A HERBAL extract promising pain relief for as much as 30 per cent of people who visit GPs will be trialled in Adelaide.

The compound, Iberogast, already has undergone numerous clinical trials overseas to prove it is effective in soothing symptoms but now researchers at the Hanson Institute hope to unlock its secrets by seeing exactly how and why it works. Read more...

Flordis support Government announcement on Complementary Medicines

Flordis Herbal Medicines support the Government announcement on Complementary Medicines

The Federal Governments tightening of the regulations covering the Complementary Medicine industry has been welcomed by Flordis Managing Director, Nigel Pollard. Read more...

Germany’s leading OTC gastro medicine - now available in Australia!

Germany’s leading OTC gastro medicine - now available in Australia!

Australians now have access to a clinically proven herbal medicine for Irritable Bowel Syndrome (IBS) and dyspepsia. Millions of people worldwide have improved the common symptoms of bloating, constipation, abdominal pain, acid reflux, nausea and fullness by using a special clinically trialled herbal medicine.
Read more...

Breaking news

1st October 2003: Flordis welcomes a new era for herbal medicines in Australia!

The report released today by the Government is an important step forward for consumers, health professionals and the industry. When implemented its recommendations will substantially improve the environment for evidence-based herbal medicines in Australia. Linking the health claims made for products with the exact herbal ingredients that have been proven in the trials ensures that consumers and health professionals can make health decisions based on the best evidence. Read more...

Product News - 18th July 2003

Flordis calls for European herbal medicine standards to be adopted in Australia

Sydney, 18 July, 2003: Unique Australian company, Flordis, supplier of clinically proven herbal medicines, is calling for Australian standards to be lifted to meet European criteria.

URGENT NEWS - 28th April 2003

The risks of taking low quality herbal medicines was confirmed today by the product recall of products manufactured by Pan Pharmaceuticals.

Flordis is the only company in Australia offering only clinically proven herbal medicines, prescribed in millions overseas every year. All Flordis products are manufactured to the highest quality standards in the world. Every Flordis product has been clinically proven, which means that the safety and effectiveness have been established to the highest level known in medicine. Read more...